Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Boosting and Guiding Neuroplasticity by Combining Ketamine with Neurofeedback-assisted Learning - Towards an Individualized and Integrated Pharmaco-psychotherapy for Cocaine Addiction

NCT06125054 is registered in ClinicalTrials.gov with Dr. med. Marcus Herdener as lead sponsor.

NCT NCT06125054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06125054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Boosting and Guiding Neuroplasticity by Combining Ketamine with Neurofeedback-assisted Learning - Towards an Individualized and Integrated Pharmaco-psychotherapy for Cocaine Addiction
Lead sponsor
Dr. med. Marcus Herdener
Phase
Phase 2
Overall status
Recruiting
Start date
February 5, 2024
Completion date
March 31, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cocaine dependence, cocaine use disorder